Please login to the form below

Personas: a top tool for personalising pharma marketing campaigns

Healthcare customers are calling for greater personalisation in care from providers. Here, we explain why personas are the top tool for ensuring your brand meets this need efficiently and effectively.
Customers’ top healthcare priority in 2018 is receiving personalised care from providers, according to a recent report by Deloitte. Their desires range from innovative customer apps, omnichannel access and patient portals in hospitals, to a better leveraging of social media, and the use of augmented and virtual reality.

From health apps, such as the UK National Health Service and Babylon’s GP at Hand, to the novel ease of genetic testing, patients now have a greater ability to monitor and understand their own healthcare needs. This, combined with the simplicity of ‘Googling’ a health problem, means customers’ expectations are changing.

The foundation of personalisation is understanding your customers. Personas are a useful tool for making sure your brand is centered on your stakeholders, without wasting time and resource on ineffective assets. As a result, they give you the ability to create tailored products and services that meet customers’ rapidly advancing expectations.

What are personas?

At its heart, a persona (right) is a decision-making tool used to empower brand teams by driving multichannel brand plans. It’s also a facilitation tool used to focus designers on developing solutions to customers’ problems. Personas are used by brands to create effective assets, but they are also used to help the wider company understand its customers.

A persona reminds us who the customer is and tells us what they require. It synthesises information about a group of customers, who share similar objectives and behaviours, and drills this data down into one fictitious customer profile, which represents the entire group of customers.

How does the customer-centric organisation use personas?

Five common principles drive personas – predictive summary of behaviour, customer insights, story, context, and memorability. These principles ensure each persona is fit for purpose.

The persona is grounded in customer insights, which are gathered in the context in which the customer would use the product or the service. The insights are consolidated into a single story about the group of customers, which highlights their frustrations and facilitates decisions. Context gives customer behaviours a purpose. By understanding the context of your product or service, you can visualise stakeholders’ frustrations and learn their unmet needs.

Personas also have to be memorable to be useful. By being concise and visual, while injecting a sense of personality, you can develop a powerful tool which can be used across the entire organisation.


Download the full article from Blue Latitude Health

14th May 2018

Share

Tags

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom

Latest content on this profile

The changing face of pharma in the precision era
Blue Latitude Health speaks to Nancy Brandt, a Senior Leader in Global Medical Information at a top 20 biopharma organisation. Here, she reveals what pharmaceutical companies need to do to prepare to bring precision medicines to market and how she is ensuring the patient is consulted every step of the way.
Blue Latitude Health
Creative problem solving, solved
Customer Experience Consultant Eimear Power explains how pharma teams can unlock their creativity and foster truly innovative ideas.
Blue Latitude Health
Three strategies for managing loss of exclusivity successfully
Claire Taylor, Senior Associate Consultant at Blue Latitude Health explains why you should be strategically planning your LOE strategy years in advance.
Blue Latitude Health
Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to make a more accurate treatment decision. Here we discuss the barriers, opportunities and potential outcomes of the precision medicine era in healthcare.
Blue Latitude Health
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist and Director of Public Health at Genomics England, to find out how the NHS is achieving this goal.
Blue Latitude Health
Diagnosing the lag in neuropsychiatric treatments
The number of mental health research programmes in larger drug firms has shrunk by 70% in the past decade. Blue Latitude Health Senior Associate Consultant Sana Rahim explores this drop in investment and explains why developing a market-orientated model is vital for making progress.
Blue Latitude Health